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Vesicular trafﬁcking such as macropinocytosis is a
dynamic process that requires coordinated interactions
between specialized proteins and lipids. A recent report
suggests the involvement of CtBP1/BARS in epidermal
growth factor (EGF)-induced macropinocytosis. Detailed
mechanisms as to how lipid remodelling is regulated
during macropinocytosis are still undeﬁned. Here, we
show that CtBP1/BARS is a physiological activator of
PLD1 required in agonist-induced macropinocytosis.
EGF-induced macropinocytosis was speciﬁcally blocked
by 1-butanol but not by 2-butanol. In addition, stimulation
of cells by serum or EGF resulted in the association of
CtBP1/BARS with PLD1. Finally, CtBP1/BARS activated
PLD1 in a synergistic manner with other PLD activators,
including ADP-ribosylation factors as demonstrated by
in vitro and intact cell systems. The present results shed
light on the molecular basis of how the ‘ﬁssion protein’
CtBP1/BARS controls vesicular trafﬁcking events includ-
ing macropinocytosis.
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Introduction
Endocytosis is a vital process required for many cellular
activities, including extracellular nutrient uptake, membrane
recycling and signal transduction. Although the pathway
initiated by clathrin-coated pits has received the most atten-
tion because of its importance in receptor-mediated capture
of external ligands (Conner and Schmid, 2003), it has recently
become clear that other endocytic pathways exist, which
serve additional physiological functions. One of these
pathways is macropinocytosis (Conner and Schmid, 2003;
Parton and Richards, 2003).
Macropinocytosis refers to the formation of large (0.2–
5mm) endocytic vesicles, called macropinosomes, by the
closure of lamellipodia generated at rufﬂing membrane
domains (for review, see Swanson and Watts, 1995).
Macropinocytosis provides an efﬁcient route for taking up
extracellular macromolecules and nutrients. In the process of
macropinocytosis, the formation of macropinosomes from
cell surface rufﬂes is highly dependent on the actin cytoske-
leton reorganization, which is spatiotemporally coordinated
by the Rho family GTPases and phosphoinositide signalling
(Araki et al, 1996, 2000, 2003; Anton et al, 2003). Although
macropinocytosis is constitutive in specialized antigen-pre-
senting cells such as macrophages and dendritic cells in
which formed macropinosomes gradually mature and
merge with the lysosomal degradative pathway (Steinman
and Swanson, 1995), it can also be rapidly and synchro-
nously induced by growth factors in other cell types in which
the ﬂuid content of macropinosomes is not delivered to the
degradation pathway, but is instead extracellularly regurgi-
tated by recycling pathways (Hewlett et al, 1994; Hamasaki
et al, 2004). The molecular mechanism underlying the for-
mation and subsequent maturation of macropinosomes is
poorly understood.
It is also known that membrane trafﬁcking is an energy-
dependent event and occurs under strict control of specia-
lized proteins such as docking and fusion proteins (Weber
et al, 1998) in concert with membrane lipid remodelling. One
of the enzymes known to be involved in membrane lipid
remodelling during vesicular trafﬁcking is phospholipase D
(PLD) (Mettlen et al, 2006). PLD generates phosphatidic acid
(PtdOH), a multifunctional lipid with many roles. It has been
proposed to alter membrane curvature, serve as a protein
attachment site and activate selected enzymes. PtdOH also
represents the starting material for the production of addi-
tional signalling lipids, particularly in the context of mem-
brane vesicle trafﬁcking and cytoskeletal dynamics (for
review, see Morris, 2007). Subsequently, CtBP1/BARS has
been identiﬁed as an important factor in the ﬁssion of the
macropinosome neck during epidermal growth factor (EGF)-
mediated macropinocytosis (Liberali et al, 2008). These ﬁndings
prompted us to study the mutual relationships between PLD
and CtBP1/BARS during agonist-induced macropinocytosis.
CtBP1/BARS (short splice variant of the CtBP1 gene) was
originally identiﬁed as a 50-kDa protein based on its ADP
ribosylation in the presence of the toxin brefeldin A (Spano `
et al, 1999). CtBP1/BARS belongs to a dual-function protein
family that is known to be involved in both membrane ﬁssion
and gene transcription (Chinnadurai, 2003; Corda et al,
2006). As a nuclear transcription factor, CtBP1/BARS
regulates numerous cellular functions, including epithelial
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1197differentiation, tumorigenesis and apoptosis (Chinnadurai,
2002; Grooteclaes et al, 2003). In the cytoplasm, CtBP1/
BARS controls the ﬁssion machinery that is involved in the
formation of post-Golgi carriers, endocytic ﬂuid-phase car-
riers (Bonazzi et al, 2005) and COPI-coated vesicles (Yang
et al, 2005). CtBP1/BARS is also involved in mitotic Golgi
partitioning (Hidalgo Carcedo et al, 2004; Colanzi et al, 2007).
Precise molecular mechanisms underlying ﬁssion control by
CtBP1/BARS are unclear.
In this study we show that CtBP1/BARS is a physiological
activator of PLD1 during agonist-induced macropinocytosis.
CtBP1/BARS activates PLD1 in a manner synergistic with
other PLD activators including ADP ribosylation factor (ARF).
The molecular mechanism underlying PLD and CtBP1/BARS-
regulated agonist-stimulated macropinosome formation
is discussed. The relationship between CtBP1/BARS and
previously reported PLD activators is also elucidated herein.
Results
PLD is required for EGF-stimulated macropinocytosis
Fluid-phase macropinocytosis was analysed in COS7 cells.
Macropinocytosis was inactive under basal conditions and
was markedly enhanced upon stimulation by EGF (Figure 1A
and B) as reported earlier (Hewlett et al, 1994). As membrane
lipid remodelling is essential for dynamic vesicular trafﬁcking
including macropinocytosis, we hypothesized that membrane
lipid-metabolizing enzyme(s) must be involved during EGF-
induced macropinocytosis. Among various candidates for
such enzymes, we focused on PLD because this enzyme is
known to be involved in various vesicular trafﬁcking steps
and to be activated by various growth factors, including EGF
(Billah and Anthes, 1990). To assess the possibility of PLD
involvement in EGF-induced macropinocytosis, the effect of
1-butanol, which is known to inhibit PLD-mediated processes
by facilitating the PLD-speciﬁc transphosphatidylation reac-
tion at the expense of PtdOH production was studied.
Importantly, EGF-induced macropinocytosis was completely
blocked by 1-butanol (Figure 1A and B). However, 2-butanol,
which is unable to facilitate transphosphatidylation by PLD,
had no effect on macropinocytosis, indicating that the
1-butanol effect was a PLD-speciﬁc and non-cytotoxic one
and that PLD-catalysed PtdOH formation may be necessary
for EGF-induced macropinocytosis. To assess further the
physiological importance of PLD in macropinocytosis, endo-
genous PLD was speciﬁcally downregulated by RNA inter-
ference and then the agonist-induced macropinocytosis was
evaluated. Both PLD1 and PLD2 isoforms are expressed in
COS7 cells with a higher ratio of PLD1/PLD2 when compared
with other cell lines (Mitchell et al, 2003). Phorbol 12-
myristate 13-acetate-induced PLD activity was downregu-
lated by almost 50% in COS7 cells transfected either with
PLD1- or PLD2-siRNA (small interfering RNA) compared with
control siRNA-treated cells (Figure 2A), conﬁrming that both
siRNAs worked properly in this system as reported earlier
(Du et al, 2004; Sonoda et al, 2007). These PLD isoform-
downregulated cells showed lower macropinocytotic activity
compared with cells treated with control siRNA, whereas
PLD1-downregulated cells exhibited stronger inhibition than
PLD2-downregulated cells (Figure 2B and C). The inhibition
of EGF-induced macropinocytosis caused either by PLD1 or
PLD2 knockdown was rescued by the co-expression of the
respective rat PLD isoforms, whereas the expression of
a lipase inactive mutant, lipase-negative (LN)-PLD1 or
LN-PLD2, did not restore macropinocytotic activity
(Figure 3A). In these rescue experiments, actin dynamics in
living COS7 cells were monitored using the actin-binding
domain of ﬁlamin fused to RFP (ABD-ﬁlamin–RFP) (Figure
3B and C). This marker enabled visualization of early stages
of EGF-induced macropinocytosis. GFP–PLD1 accumulated in
the membrane-rufﬂed area of the cells that invaginated
inward to form cup-shaped structures (Figure 3B, see ar-
rows). It is interesting to note that transfected LN-PLD1 also
accumulated in the membrane-rufﬂed area but failed in
subsequent closure of invaginated and cup-shaped structures
(Figure 3C, see arrows), suggesting that PLD1 activity is
necessary for early stages of macropinocytosis. Expression
of PLD2 also rescued the EGF-induced macropinocytosis in
PLD2-knockdown cells. In contrast to PLD1, however, PLD2
accumulation surrounding macropinosomes was observed at
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Figure 1 Requirement of PLD for EGF-induced macropinocytosis.
(A) COS7 cells were serum-starved for 1h and stimulated with
100ng/ml EGF in the presence of tetramethylrhodamine-labelled
dextran for 8min in the absence or presence of 0.2% 1-butanol or
2-butanol, washed, ﬁxed and analysed for macropinocytosis by
confocal microscopy. One representative experiment from at least
three separate experiments is shown here. Cells are outlined. Bars,
10 mm. (B) Quantiﬁcation of macropinocytosing cells treated as in
(A). Data are means±s.e. from at least four independent experi-
ments carried out in triplicate.
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Figure 2 Effect of PLD downregulation by subtype-speciﬁc siRNAs on EGF-induced macropinocytosis. (A) COS7 cells were transfected with
control or PLD subtype-speciﬁc siRNAs and cultured for 30h. Cells were then metabolically labelled with radioactive lysophosphatidylcholine
for 18h and assayed for PLD in the presence of 0.3% 1-butanol. PtdBut, phosphatidylbutanol. (B) Transfected cells as in (A) were serum-
starved for 1h and stimulated with 100ng/ml EGF in the presence of tetramethylrhodamine-labelled dextran for 8min, washed, ﬁxed and
analysed for macropinocytosis by confocal microscopy. Bars, 10mm. (C) Quantiﬁcation of macropinocytosing cells treated as in (B). Data are
means±s.e. from at least four independent experiments carried out in triplicate. *Po0.05 and **Po0.01 compared with control siRNA.
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Figure 3 Rescue of PLD subtype-speciﬁc downregulation-induced inhibition of macropinocytosis by the expression of individual subtypes.
(A) COS7 cells were transfected with control or PLD subtype-speciﬁc siRNAs. After 6h, cells were transfected with expression vectors encoding
both RFP–ABD-ﬁlamin and GFP, GFP–PLD1 or GFP–PLD2 and cultured for 30h. Cells were serum-starved for 1h and stimulated with 100ng/
ml EGF in the presence of Alexa Fluor 647-labelled dextran for 8min, washed and analysed by confocal microscopy. Macropinocytosing cells
were quantitated. Data are the means±s.e. of ﬁve independent experiments carried out in triplicate. (B, C) Both RFP–ABD-ﬁlamin and GFP-
fused PLD subtypes were expressed in PLD subtype siRNA-treated COS7 cells as in (A). Representative frames of time-lapse images for GFP–
PLD1 or GFP–LN-PLD1 (green), RFP–ABD-ﬁlamin (red) and Alexa Fluor 647-labelled dextra (blue) and merged signals are shown. Arrows
indicate newly forming macropinosomes. Bars, 10mm.
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treatment) in COS7 cells transiently expressing GFP–PLD2
(see Supplementary Figure 1).
Both CtBP1/BARS and PLD are required
for EGF-stimulated macropinocytosis
As it has recently been reported that a ‘ﬁssion protein’ CtBP1/
BARS is required for EGF-induced macropinocytosis (Liberali
et al, 2008), the involvement of both PLD and CtBP1/BARS in
EGF-induced macropinocytosis was assessed. Consistently,
EGF-induced macropinocytosis was markedly diminished in
cells where endogenous CtBP1/BARS was downregulated by
treatment with CtBP1/BARS-siRNA (Figure 4A and B), con-
ﬁrming an important role of this protein in this phenomenon.
Next, we introduced puriﬁed FLAG–CtBP1/BARS into CtBP1/
BARS-downregulated COS7 cells using a BioPORTER reagent
(see Materials and methods) and macropinocytosis was
analysed. Even though this reagent itself had inhibitory
effects on macropinocytosis, introduced CtBP1/BARS re-
stored the inhibitory effects on macropinocytosis caused by
CtBP1/BARS-siRNA to some extent (Figure 4C). Importantly,
this CtBP1/BARS-supported macropinocytosis in EGF-treated
cells was potently suppressed by treatment with 1-butanol
but not with 2-butanol, suggesting strongly that PLD- and
CtBP1/BARS-mediated signals are converging into a common
pathway and not acting separately.
Requirement of CtBP1/BARS for agonist-induced
PLD activation in intact cells
It is well known that PLD is activated by a variety of growth
factors and cytokines, including EGF and serum, in various
types of mammalian cells. The observation that both CtBP1/
BARS and PLD were required for EGF-induced macropinocy-
tosis prompted us to assess the causal relationship between
the two proteins. First, we studied the effect of CtBP1/BARS
on agonist-stimulated PLD activation. When COS7 cells
were stimulated with EGF, PLD was activated as assessed
by the accumulation of PtdBut in the presence of 1-butanol
in culture medium (Figure 5). Serum also induced PLD
activation as reported earlier (Billah and Anthes, 1990).
Importantly, when cellular CtBP1/BARS was downregulated
by CtBP1/BARS-targeted gene silencing, EGF- or serum-induced
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Figure 4 CtBP1/BARS and PLD are required for EGF-stimulated macropinocytosis. (A) COS7 cells were transfected with control or CtBP1/
BARS-siRNA and cultured for 48h. Cells were serum-starved for 1h and stimulated with 100ng/ml EGF in the presence of tetramethylrho-
damine-labelled dextran for 8min, washed, ﬁxed and analysed for macropinocytosis by confocal microscopy. (B) CtBP1/BARS-siRNA-
transfected cells were administrated with either control vehicle or puriﬁed recombinant CtBP1/BARS (200nM) with the BioPORTER reagent.
Macropinocytosis assay was carried out as above in the presence or absence of 0.2% 1-butanol or 2-butanol. One representative experiment
from at least three separate experiments is shown here. Bars, 10mm. (C) Quantiﬁcation of macropinocytosing cells treated as in (B). Data are
means±s.e. from at least three independent experiments carried out in triplicate.
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CtBP1/BARS is required for the agonist-induced PLD activa-
tion. To gain further insight into the molecular mechanisms
underlying the involvement of CtBP1/BARS in agonist-in-
duced PLD activation, we analysed the interaction between
CtBP1/BARS and PLD before and after agonist stimulation.
Endogenous CtBP1/BARS was immunoprecipitated from
COS7 cell lysates prepared from the cells treated with or
without EGF or serum and immunoprecipitated beads were
subjected to PLD assay. EGF or serum stimulation of COS7
cells caused increase in PLD activity pulled down with
CtBP1/BARS-containing beads (Figure 6), indicating that
EGF or serum stimulation of cells facilitated the association
of the two endogenous proteins in intact cells. In mammals,
there are two PLD isoforms, PLD1 and PLD2. To identify the
PLD isoform involved in this interaction, COS7 cells
were transiently transfected with either PLD1 or PLD2 and
endogenous CtBP1/BARS was immunoprecipitated using
anti-CtBP1/BARS antibody and associated PLD isoform was
identiﬁed by immunoblot analysis. In the cells expressing
PLD1, CtBP1/BARS was associated with this isoform in a
serum-dependent manner (Figure 7A and B). This association
was diminished again under low serum conditions (data not
shown). These results suggest that PLD1 has the capacity to
associate with CtBP1/BARS in a manner reversibly regulated
by serum. On the other hand, PLD2 showed relatively higher
association with CtBP1/BARS under the basal conditions
and the association changed little even under high serum
conditions (Figure 7C and D). These results suggest that
agonists such as serum may induce CtBP1/BARS association
with PLD1 under physiological conditions as seen in Figure 6.
To support this notion in an endogenous cell system, PLD
activity pulled down by anti-CtBP1/BARS antibody in cell
lysates prepared from serum-stimulated cells was stimulated
by the small G-protein ARF1 (Figure 6), an activity character-
istic of PLD1 (Exton, 1999).
To demonstrate more clearly that EGF-induced association
of PLD1 and CtBP1/BARS is implicated in the formation of
macropinosomes, we monitored the dynamics of these pro-
teins during macropinocytosis in living cells. COS7 cells
transiently expressing both GFP–PLD1 and CFP–CtBP1/
BARS were stimulated with EGF and the dynamics of these
ﬂuorescent proteins during macropinocytosis were visualized
by time-lapse confocal microscopy (Figure 8). GFP–PLD1
distributed predominantly in the cytoplasm in a reticular
pattern, whereas CFP–CtBP1/BARS was localized in the
cytoplasm in a diffuse pattern. On stimulation with EGF,
both proteins gathered around newly macropinocytosing
areas in a concurrent manner, that is, these two proteins
gathered almost simultaneously around macropinocytosing
cups (Figure 8, see arrows and arrowheads). These results
suggest functional roles for both proteins in the induction of
macropinocytosis.
CtBP1/BARS activates PLD1 but not PLD2 in vitro
Next, the ability of CtBP1/BARS to activate PLD was tested in
a puriﬁed in vitro system. In contrast to bacterial and plant
PLDs, mammalian enzyme is latent in its activity in a puriﬁed
system and requires several cofactors such as phosphatidyl-
inositol 4,5-bisphosphate (PtdIns 4,5-P2) (Brown et al, 1993)
and phosphatidylethanolamine (Nakamura et al, 1996) to
express high activity. For this reason, the effect of CtBP1/
BARS on PLD activity was measured in mixed phospholipid
vesicles (Brown et al, 1993). Importantly, CtBP1/BARS
doubled PLD1 activity (Figure 9A). PLD2 activity was un-
affected by CtBP1/BARS (Figure 9B). These results are con-
sistent with the observation that association of CtBP1/BARS
with PLD1 but not PLD2 increased after serum stimulation of
COS7 cells (Figure 7). The activation of PLD1 by CtBP1/BARS
was further characterized by using various combinations of
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Figure 5 Requirement of CtBP1/BARS for agonist-induced PLD
activation. COS7 cells were transfected either with control or with
CtBP1/BARS-siRNA and cultured for 30h. Cells were then metabo-
lically labelled with radioactive lysophosphatidylcholine for 18h in
the absence of serum. After stimulation of cells with 100ng/ml EGF
for 8min or with various concentrations of fetal calf serum for
30min in the presence of 0.3% 1-butanol, accumulation of PtdBut
in the cells was measured and expressed as a percentage of total
radioactivity. Data are the means±s.e. of three independent experi-
ments carried out in triplicate. PtdBut, phosphatidylbutanol.
*Po0.05 and **Po0.01 compared with control siRNA.
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Figure 6 Serum induces association of CtBP1/BARS with native
PLD. After serum starvation for 16h, COS7 cells were stimulated
with 100ng/ml EGF or 10% fetal calf serum for 30min. Cells were
lysed and immunoprecipitated with anti-CtBP1/BARS antibody.
Pulled down PLD-associated with CtBP1/BARS was assayed for
PtdBut production in the absence or presence of 50nM ARF. Data
presented are means±s.e. of six independent experiments carried
out in triplicate. *Po0.05 compared with no addition of agonists.
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cytosis (Cohen et al, 2007) and a well-characterized subtype
known to activate PLD, was also tested for its ability to
stimulate PLD in concert with CtBP1/BARS. When both
CtBP1/BARS and ARF1 were added in the PLD assay, syner-
gistic activation was observed in a manner dependent on
GTPgS or GTP but not on GDP (Figure 9C), suggesting that
CtBP1/BARS synergizes with the active form of ARF1. As
ARF6 is also considered to be an important regulator for
macropinocytosis (Donaldson et al, 2009) along with the
observation of ARF6 accumulation surrounding the newly
formed macropinosomes (see Supplementary Figure 2), the
ability of this ARF subtype was also assessed for PLD activa-
tion with other known PLD activators, RhoA (Bowman et al,
1993; Malcolm et al, 1994) and protein kinase Ca (PKCa)
(Conricode et al, 1992; Singer et al, 1996). ARF6- and
RhoA-supported PLD activity was further stimulated by
CtBP1/BARS to 2.8- and 2.1-fold, respectively, although
further stimulation of PKCa-supported PLD activity was not
further enhanced by CtBP1/BARS (Figure 9D). Interestingly,
simultaneous addition of all these proteins caused a robust
activation of PLD1, suggesting that CtBP1/BARS causes a
synergistic activation of PLD1 with other activators and
that CtBP1/BARS is acting on a site of PLD1 distinct from
the sites for previously reported PLD activators. Furthermore,
it has recently been reported that during EGF-induced
macropinocytosis, CtBP1/BARS undergoes p21-activated
kinase-dependent phosphorylation at Ser-147, which is
important for translocation to the macropinocytic cup and
its surrounding membranes and subsequent ﬁssion of the
macropinocytic cup (Liberali et al, 2008). To explain these
phenomena through PLD-mediated signalling, we prepared
the phosphorylation mimicking mutant of CtBP1/BARS,
CtBP1/BARS (S147D) and tested its ability to stimulate PLD
activity. As expected, this mutant showed about two-fold
higher capacity to stimulate PLD1 as compared with wild-
type CtBP1/BARS (Figure 9D).
Discussion
CtBP1/BARS was originally identiﬁed as an ADP ribosylation
substrate in the presence of the toxin brefeldin A (Spano ` et al,
1999) and later implicated in dynamin-independent endocy-
tosis and ﬁssion of the Golgi membranes (Corda et al, 2006).
CtBP1/BARS was originally thought to possess intrinsic
lysophosphatidic acid acyltransferase activity inducing
membrane ﬁssion (Weigert et al, 1999). Weigert et al also
suggested that CtBP1/BARS was unable to activate PLD:
under conditions where PtdOH synthesis by Golgi
membranes was stimulated by CtBP1/BARS in the presence
of radioactive palmitoyl-CoA, the labelling pattern of
other lipids was unchanged. This was a useful model to
explain the mechanism underlying the generation of PtdOH
during CtBP1/BARS-induced membrane ﬁssion. However,
the enzymatic activity of various mutants of CtBP1/BARS
does not correlate with the membrane ﬁssion activity
(Hidalgo Carcedo et al, 2004). More recently, observations
have revealed that CtBP1/BARS does not possess intrinsic
acyltransferase activity and that the activity associated
with CtBP1/BARS was a co-puriﬁcation artefact (Gallop
et al, 2005).
In this study, we have shown that CtBP1/BARS is involved
in PLD1 activation and that this PLD activation is required for
EGF-induced macropinocytosis. CtBP1/BARS activation of
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Figure 7 Serum induces CtBP1/BARS association with recombinant PLD1. COS7 cells were transiently transfected with expression vectors
encoding either FLAG–PLD1 (A, B) or FLAG–PLD2 (C, D) and cultured for 2 days. After serum starvation for 12h, cells were stimulated with
10% fetal calf serum, lysed, immunoprecipitated with anti-CtBP1/BARS antibody and subjected to immunoblot analysis (A, C). The amounts of
FLAG–PLD1 (B) or FLAG–PLD2 (D) pulled down with CtBP1/BARS in immunoblots (A, C) were quantitated. One representative experiment
from at least three separate experiments is shown here. It is noted that serum treatment results in increased association of CtBP1/BARS with
PLD1.
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EGF stimulation of PLD required CtBP1/BARS (Figure 5).
Second, serum stimulation resulted in the association of
CtBP1/BARS with PLD1 as assessed by an endogenous
(Figure 6) or recombinant protein system (Figure 7).
Finally, CtBP1/BARS activated PLD1 in vitro (Figure 9).
Conversely, the present results showed that not only PLD1-
siRNA treatment but PLD2 downregulation also inhibited
EGF-induced macropinocytosis, which was rescued by the
co-expression of wild-type PLD2 but not by catalytically
inactive mutant LN-PLD2 (Figure 3).
The spatiotemporal involvement of PLD subtypes in
macropinocytosis was further assessed during EGF-induced
macropinocytosis using time-lapse video monitoring.
PLD1 was recruited at earlier stages of macropinocytosis
especially from the beginning to closure steps in a manner
concurrent with CtBP1/BARS (Figures 3 and 8). On the
other hand, PLD2 but not LN-PLD2 surrounded macropino-
somes at relatively later stages of macropinocytosis
(Supplementary Figure 1). These results strongly suggest
that PLD1 and PLD2 participate in macropinocytosis differ-
ently, that is, PLD1 regulates macropinocytosis at the earlier
steps presumably at the formation and the closure of macro-
pinocytic cups with the aid of CtBP1/BARS (Liberali et al,
2008), whereas PLD2 may participate in subsequent steps of
macropinosome trafﬁcking with mechanisms of regulation
currently unknown. In terms of enzyme regulation, PLD1
differs from PLD2, that is, PLD1 is regulated by various
protein and lipid factors (see below), whereas PLD2 is
insensitive to most of these protein factors but is regulated
strongly, at least in vitro, by PtdIns 4,5-P2. It may be inter-
esting to surmise that PLD1 is mainly implicated in the
phenomena that are controlled by key proteins such as
ARF, PKC and CtBP1/BARS, whereas PLD2 may participate
generally in the phenomena involving membrane lipid dy-
namics during vesicular trafﬁcking.
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Figure 8 Involvement of both PLD1 and CtBP1/BARS in EGF-induced macropinocytosis. COS7 cells were transiently co-transfected with
expression vectors encoding GFP–PLD1 or CFP–CtBP1/BARS and cultured for 2 days. Cells were serum-starved for 1h and stimulated with
100ng/ml EGF in the presence of tetramethylrhodamine-labelled dextran and analysed for macropinocytosis by confocal microscopy.
Representative frames of time-lapse images for GFP–PLD1 (green), CFP–CtBP1/BARS (grey) and tetramethylrhodamine-labelled dextran
(red) and merged signals are shown. Arrows and arrowheads indicate newly forming macropinosomes. Bars, 10mm.
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latent in its basal activity and is activated upon stimulation of
cells by a wide variety of agonists including growth factors
and cytokines (Billah and Anthes, 1990). Subsequently, var-
ious activators of PLD, especially PLD1 have been identiﬁed
in an in vitro system using mixed phospholipid vesicles for
example, the 50-kDa protein (Bourgoin et al, 1995; Lambeth
et al, 1995), ARF (Brown et al, 1993; Cockcroft et al, 1994),
PKCa (Conricode et al, 1992; Singer et al, 1996), GM2 acti-
vator (Nakamura et al, 1998), PtdIns 4,5-P2 (Brown et al,
1993; Liscovitch et al, 1994) and phosphatidylethanolamine
(Nakamura et al, 1996). Although the 50-kDa protein was
described in earlier studies using neutrophils, the nature of
this protein remains undeﬁned. It is possible that CtBP1/
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Figure 9 Activation of PLD1 by CtBP1/BARS in a puriﬁed recombinant protein system. PLD1 (A) and PLD2 (B) activities were measured as a
function of time in the absence or presence of 10nM CtBP1/BARS using mixed phospholipid vesicles. PLD1 activity was reconstituted with
various combinations of 1nM CtBP1/BARS and 50nM ARF1 in the absence or presence of 100mM guanine nucleotides (C) or with various
combinations of 1nM CtBP1/BARS, 1nM CtBP1/BARS(S147D), 4nM ARF6, 300nM RhoA and 100nM PKCa (D). Enzymatic reactions
proceeded for 20min and PtdEtOH formation was measured. Data presented are means±s.e. of at least six independent experiments carried
out in triplicate. *Po0.05 compared with no addition of activators. PtdEtOH, phosphatidylethanol.
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related, as both proteins are cytoplasmic proteins with a
molecular mass of 50-kDa that activate PLD1 synergistically
with ARF. In fact, treatment of the cytosolic fractions ob-
tained from various tissues with anti-CtBP1/BARS antibody
resulted in the depletion of PLD stimulatory activities in the
fractions around 50-kDa as estimated by molecular-sieve
column chromatography (data not shown). As information
on the 50-kDa PLD activator is available only for granulocytes
and HL60 cells, further studies are necessary to elucidate the
relationship between CtBP1/BARS and the 50-kDa PLD acti-
vator in greater detail.
It has been reported that CtBP1/BARS controls the ﬁssion
events in the formation of post-Golgi carriers (Bonazzi et al,
2005), COPI-coated vesicles (Yang et al, 2005) and macro-
pinosomes (Liberali et al, 2008). In this study, we have
demonstrated that PLD activation is required for agonist-
induced macropinocytosis. PtdOH generated by PLD may
recruit and activate downstream effectors, or change the
biophysical properties of the membrane and directly induce
membrane bending and/or destabilization. As the local gen-
eration of PtdOH has a key function in the regulation of
vesicular trafﬁcking including formation of post-Golgi car-
riers (Sweeney et al, 2002) and COPI-coated vesicles
(Abousalham et al, 2002), it is important to clarify the role
of CtBP1/BARS in the regulation of PLD in these phenomena.
Materials and methods
Cell cultures
COS7 cells were cultured in Dulbecco’s modiﬁed Eagle’s medium
(DMEM) containing 10% fetal calf serum, 100U/ml penicillin and
100 mg/ml streptomycin in a humidiﬁed atmosphere containing 5%
CO2 at 371C.
Plasmid construction
The rat PLD1 cDNA was a generous gift from Dr JH Exton (Howard
Hughes Medical Institute, Vanderbilt University). The rat PLD2
cDNAwas isolated by reverse transcription–PCR from total RNAs of
rat brain as reported earlier (Sarkar et al, 2001). The rat ARF6 cDNA
(DDBJ/EMBL/GenBank accession number NM024152) was isolated
from total RNAs of rat brain by PCR (sense primer, 50-TGAAGCTTG
CCACCATGGGGAAGGTGCTATCC-30 and antisense primer, 50-TGA
AGCTTGGATTTGTAGTTAGAGGT-30). The human actin-binding
domain of ﬁlaminB (ABD-ﬁlamin) cDNA (DDBJ/EMBL/GenBank
accession number NM001457) was ampliﬁed from a human liver
cDNA library by PCR (sense primer, 50-TGAAGCTTTGGAAGAAGA
TCCAGCAG-30 and antisense primer, 50-TGAAGCTTGAACTGGGACA
GGTAAGT-30) using KOD-PLUS polymerase (Toyobo, Tokyo). Site-
directed mutagenesis of PLD isoforms was performed using the
QuikChange site-directed mutagenesis kit (Stratagene, La Jolla, CA)
to prepare LN mutants. The primers used were as follows: LN-PLD1
(K860R), 50-GCTCATCTATGTCCACAGCAGGTTGTTAATTGCTGAT
G-30 and 50-CATCAGCAATTAACAACCTGCTGTGGACATAGATGAGC-
30; LN-PLD2 (K758R), 50-CATCTATATCCACAGCAGGTTGCTCATTGC
AGATGAC-30 and 50-GTCATCTGCAATGAGCAACCTGCTGTGGATATA
GATG-30. The full-length cDNAs encoding PLD1, LN-PLD1, PLD2,
LN-PLD2 or ARF6 were subcloned into the mammalian expression
vectors pCMV5, pEGFP-C1 (for PLD constructs), or pEGFP-N1 (for
ARF6) to express FLAG–PLD1, FLAG–PLD2, ARF6–FLAG, GFP-PLD1,
GFP-PLD2, or ARF6-GFP, respectively. ABD-ﬁlamin was subcloned into
the mammalian expression vector pDsRed-Monomer C1 to express N-
terminal red ﬂuorescent protein-fused protein (RFP–ABD-ﬁlamin).
The rat CtBP1/BARS (rCtBP1/BARS) cDNA (DDBJ/EMBL/
GenBank accession number NM019291) was ampliﬁed from a rat
brain cDNA library by PCR (sense primer, 50-TGGAATCCAATGTCAG
GCGTCCGACCTCC-30 and antisense primer, 50-TGGAATCCCTACAA
CTGGTCAGTCGTAT-30) using ExTaq polymerase (Takara, Otsu,
Japan). The full-length CtBP1/BARS was subcloned into the
mammalian expression vector pCMV5 or pECFP-C1 to express
N-terminal FLAG-tagged or CFP fusion proteins, respectively. Site-
directed mutagenesis of rCtBP1/BARS was performed using the
QuikChange site-directed mutagenesis kit to prepare FLAG-tagged
rCtBP1/BARS(S147D). The primers used were as follows: sense
primer, 50-GCACTCGGGTCCAGGATGTAGAGCAGATCC-30 and anti-
sense primer, 50-GGATCTGCTCTACATCCTGGACCCGAGTGC-30.
All constructs were veriﬁed by DNA sequencing.
siRNA for CtBP1/BARS
siRNAs for human CtBP1/BARS (50-CCGUCAAGCAGAUGAGACAd
TdT-30 and 50-GAGCAGGCAUCCAUCGAGAdTdT-30,5 0-GCUCGCACU
UGCUCAACAAdTdT-30 and 50-GGAUAGAGACCACGCCAGUdTdT-30;
dT is deoxyribosylthymine throughout) human PLD1 (50-GUUAA
GAGGAAAUUCAAGCdTdT-30 and 50-GCUUGAAUUUCCUCUUAACd
TdT-30), human PLD2 (50-GACACAAAGUCUUGAUGAGdTdT-30
and 50-CUCAUCAAGACUUUGUGUCdTdT-30) and the control
siRNA (50-UUCUCCGAACGUGUCACGUdTdT-30 and 50-ACGUGACAC-
GUUCGGAGAAdTdT-30) were synthesized at Japan Bio Services
Saitama, Japan. COS7 cells were transfected with the siRNAs using
Oligofectamine according to the manufacturer’s instructions (In-
vitrogen, Carlsbad, CA, USA). After transfection, the intracellular
CtBP1/BARS levels were assessed by immunoblotting and the cells
were further processed according to the various experimental
procedures as necessary.
Immunoprecipitation
CtBP1/BARS-speciﬁc polyclonal antibody was raised in rabbits
against a full-length CtBP1/BARS fused with glutathione S-
transferase. This antibody can be used for immunoblotting and
immunoprecipitation.
For immunoprecipitation, COS7 cells were lysed with the lysis
buffer (20mM HEPES/NaOH, pH 7.4, 2mM MgCl2, 1mM EGTA, 1%
octylglucoside, 1mM DTT, 20mg/ml leupeptin and 0.1% ovalbu-
min) for 30min on ice. The lysates were clariﬁed by centrifugation
for 15min at 15000g and incubated with anti-CtBP1/BARS
antibody adsorbed protein A-Sepharose beads at 41C for 16h. The
immunoprecipitates were subjected to immunoblot analysis or PLD
assay.
Puriﬁcation of recombinant proteins
Recombinant PLD1, PLD2 and CtBP1/BARS were puriﬁed from
COS7 cells transiently expressing FLAG–PLD1, FLAG–PLD2 or tag-
free CtBP1/BARS using either anti-FLAG antibody M2 beads
(Sigma) or anti-CtBP1/BARS antibody-adsorbed protein A-Sephar-
ose beads and ﬁnally eluted with FLAG peptide (Sigma) or 0.1M
glycine (pH 3.5), respectively, and used for in vitro assay.
Recombinant N-myristoylated human ARF1 was prepared from
Escherichia coli expressing recombinant human ARF1 and human
myristoyltransferase (kind gifts from Dr RA Kahn, Emory Uni-
versity, Atlanta) and puriﬁed to near homogeneity (more than 90%
purity) by sequential column chromatography on DEAE Sephacel
and Superdex 75 as described earlier (Randazzo and Kahn, 1995).
Introduction of recombinant CtBP1/BARS into cells
Puriﬁed recombinant FLAG–CtBP1/BARS was delivered into COS7
cells using the BioPORTER reagent (Sigma) according to the
manufacturer’s instructions. Brieﬂy, puriﬁed recombinant FLAG–
CtBP1/BARS (2.5mg) was diluted in PBS, added to BioPORTER dry
ﬁlm and mixed by pipetting, then mixed with 250ml of serum-free
medium and added to cells cultured in Lab-Tec Permanox four-
chamber slides (Nunc) for 4h. Cells were subsequently used for
macropinocytosis assays.
PLD assay
In vitro PLD activity was determined with PtdIns 4,5-P2-containing
mixed lipid vesicles essentially as described earlier (Brown et al,
1993). Under the standard assay conditions, the reaction mixture
(100ml) contained 5mM[
14C]PtdCho (55000 d.p.m./nmol), 80mM
PtdEtn, 7mM PtdIns 4,5-P2, 20mM HEPES/NaOH, pH 7.4, 2%
ethanol, 1mM MgCl2, puriﬁed recombinant FLAG–CtBP1/BARS,
PLD1 or PLD2. In some experiments, various combinations of
myristoylated ARF1, FLAG-tagged ARF6, hexahistidine-tagged
RhoA (Cytoskeleton, Denver) and hexahistidine-tagged PKCa (Jena
Bioscience, Jena, Germany) were added in the reaction. After
various times of incubation at 371C, reactions were stopped by the
addition of 1ml of ice-cold chloroform–methanol–HCl (1:1:0.006,
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(Nakamura et al, 1995).
For in vivo PLD assays, cells were metabolically labelled with
[
14C]lysophosphatidylcholine (0.5mCi/1 10
7 cells; GE Healthcare,
Buckinghamshire, UK) for 18h in the absence of serum. After
washing with PBS, PLD reaction was initiated by adding DMEM
containing 0.3% 1-butanol in the absence or presence of 100ng/ml
EGF or fetal calf serum. Termination of the reactions, lipid
extraction and lipid separation were carried out as above. PLD
activity was expressed as a percentage of [
14C]PtdBut in the total
radioactivity found in all spots in one lane.
Macropinocytosis assays
Macropinocytosis assays were carried out essentially as described
earlier (Liberali et al, 2008). COS7 cells were cultured on Lab-Tec
Permanox 4-chamber slides (Nunc). Cells were incubated for 1h in
serum-free Ringer’s buffer (155mM NaCl, 5mM KCl, 1mM MgCl2,
2mMNa 2HPO4, 10mM glucose, 10mM HEPES/NaOH, pH 7.2 and
0.5mg/ml BSA). The serum-starved cells were stimulated with
100ng/ml EGF for 8min in the presence of 0.5mg/ml tetramethylr-
hodamine-labelled 10kDa dextran (Molecular Probes) or Alexa
Fluor 647-labelled dextran (Invitrogen), as probes of ﬂuid-phase
macropinocytosis in Ringer’s buffer. The cells were then washed to
remove the unbound dextran, ﬁxed with 4% paraformaldehyde and
analysed for macropinocytosis by confocal microscopy. Cells
showing 10 and more dextran-positive structures were considered
to be macropinocytosing and were scored positive for macropino-
cytosis. The levels of macropinocytosis are given as percentages of
the total cells in this scoring category.
Supplementary data
Supplementary data are available at The EMBO Journal Online
(http://www.embojournal.org).
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